INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
2,370 sh
Jan 16, 2026Jan 21, 2026
Page 1473 of 1835
← PrevNext →
traded Jan 16, 2026
+5d
SEC Form 4

Evidence

19
SB
Sicinski Matthew B.Senior VP and CAO
SMCSummit Midstream Corp
Option exercise
M—
3,593 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
DH
Deneke J HeathChairman, President and CEO
SMCSummit Midstream Corp
Option exercise
M—
32.8K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
JD
Johnston James DavidExecutive VP, GC, CCO and Secy
SMCSummit Midstream Corp
Option exercise
M—
10.8K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
MJ
Mault William J.Executive VP and CFO
SMCSummit Midstream Corp
Option exercise
M—
10.1K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
400 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC Form 4

Evidence

19
PM
Patil Neena MEVP & Chief Legal Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
8,852 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
266 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC Form 4

Evidence

19
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Option exercise
M—
1,367 sh
Jan 18, 2026Jan 21, 2026
traded Jan 18, 2026
+3dSEC Form 4

Evidence

19
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Tax withholding
F$12K
1,595 sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,250 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC Form 4

Evidence

19
HD
Harris Kimberley D.Director
GSGOLDMAN SACHS GROUP INC
Grant or award
A—
364 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
2,001 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WT
Weitzel Gregory ThomasCFO
MATVMativ Holdings, Inc.
Tax withholding
F$35K
2,798 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
VE
Vestberg Hans ErikDirector
BLKBlackRock, Inc.
Grant or award
A—
214 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
40.1K sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

19
JL
Johnson Margaret LDirector
BLKBlackRock, Inc.
Grant or award
A—
214 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Tax withholding
F$89K
12.1K sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

18
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$97K
1,141 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
MJ
Mault William J.Executive VP and CFO
SMCSummit Midstream Corp
Tax withholding
F$74K
2,757 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
DH
Deneke J HeathChairman, President and CEO
SMCSummit Midstream Corp
Tax withholding
F$220K
8,216 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$115K
1,357 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$190K
2,237 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$117K
1,382 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Tax withholding
F$53K
622 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$54K
632 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$73K
10.0K sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

18
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$55K
644 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$192K
2,259 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
TK
Talluri Rajendra KDirector, President and CEO
ENVXEnovix Corp
Tax withholding
F$153K
18.5K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$120K
1,409 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$60K
12.4K sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

17
SD
Smith DironEVP, Chief Financial Officer
ITGRInteger Holdings Corp
Option exercise
M—
1,709 sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence

17
SC
Selecky ChristobelDirector
IBRXImmunityBio, Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

17
SJ
Stephens JimPresident, CRM & Neuro
ITGRInteger Holdings Corp
Tax withholding
F$38K
447 sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence

17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$61K
12.1K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

17
CB
Cree BrianPresident
VTSVitesse Energy, Inc.
Open-market sale · 10b5-1 plan
SELL$348K
18.0K sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence